Recombinant cytochrome P450, isozyme 2C9, (CYP2C9) may be used in toxicity and drug metabolism/ pharmacokinetics research to identify its specificity and activity versus xenobiotic and endogenous compounds. Recombinant cytochrome P450, isozyme 2C9, may be used separately or as a component of a P450 isozyme panel to identify and characterize natural and synthetic selective inhibitors that affect the metabolism of toxic compounds or therapeutic drugs such as warfarin, bosentan, and fluoxetine.
一般的な説明
Microsome contents of CYP2C9 human and yeast CYP-reductase expressed in Saccharomyces cerevisiae.
